Press

November 27, 2023 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, has announced additions to its Oncology Program Board. The SCRS Oncology Program is dedicated to advancing the sustainability and effectiveness of oncology sites by identifying their unique needs and creating strategic resources to address these challenges. Through collaboration with corporate and site partners, our mission is to foster a dynamic environment that encourages the identification and development of solutions for the oncology research community. The newly appointed members were carefully selected based on their extensive expertise and rich experience in the field of oncology research. The recently added members of the Oncology Board include: Courtney Alexander, Senior Operations Manager & Contract and Budget Specialist, Centricity Research Radhika Butala, Clinical Trial & Research Unit Manager, Westmead Private Hospital (Part of Ramsay Health Care & Ramsay Clinical Trials Network) Angela Fritsche, Operations Administrator, Mayo Clinic Comprehensive Cancer Center Clinical Trials Office Angela Galindo, Director of Site Development & Quality Assurance, The START Center for Cancer Care Jennifer Hunter, Director of Research Operations, Mary Crowley Cancer Center Zin Htway, Supervisor & Operations Manager of Anatomic Pathology, HCA Los Robles Hospital & Medical Center Jessica Moehle, Senior Clinical Research Administrative Director, Huntsman Cancer Institute Thobekile Mthethwa-Pitt, Trial Hub Senior Education & Quality Manager, Alfred Health John Musser, Senior Director, Clinical Research Administration, Florida Cancer Specialists & Research Institute Lynda Owen, Associate Director, Research Program Development & Education, Duke Cancer Network Sevtap Rowlands, Director of Clinical Operations, 4 Medical Clinical Solutions T.J. Sharpe, Patient Engagement Program Manager, Medidata Solutions Johnny Walker, Director of Research, Utah Cancer Specialists Rachel Wong, Clinical Trials Unit Manager, Gallipoli Medical Research Foundation Jimmy Bechtel, SCRS VP of Site Engagement, shared, “As SCRS continues its mission to advance the sustainability and effectiveness of oncology sites, the unique insights and expertise of our newly appointed members will play a pivotal role in identifying and developing resources that will benefit the entire oncology research community. Their dedication to creating opportunities for innovation and excellence in oncology research will undoubtedly shape the future of the program.” To learn more about the SCRS Oncology Program visit myscrs-new.local/about/scrs-oncology-program. About the Society for Clinical Research Sites The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

November 2, 2023 – The Society for Clinical Research Sites (SCRS) is proud to announce a strategic Global Impact Partnership with Science 37, marking the Society’s first and only fully virtual clinical trial site to participate in its expansive Global Impact Partner community. “We are excited to announce our partnership with SCRS,” said David Coman, CEO of Science 37. “The Science 37 Metasite™ is at the forefront of a clinical research shift, as it breaks down geographical barriers and makes clinical trials more accessible. We look forward to collaborating with the SCRS team, along with its network of clinical research sponsors and sites to deliver a more patient-friendly and impactful research ecosystem.” Science 37’s unique model reaches patients who do not have access to traditional brick-and-mortar clinical trial sites and enables them to participate from the comfort of their homes. Oversight is managed by telemedicine investigators, physical procedures are managed by mobile nurses, and patient support is provided by remote coordinators. The experience is powered by a proprietary platform that enables data collection and workflow orchestration that drives greater compliance to produce high-quality data. Marcus Maleck, Vice President of Global Business Partnerships with SCRS also expressed enthusiasm about the collaboration, stating, “Science 37 is a pioneer in our industry ever since launching their decentralized clinical trials platform. Now, as the clinical research landscape evolves, they are incorporating their technology and expertise to expand patient access to trials. Their work in clinical trial innovation is invaluable to our site members and the industry as a whole. We look forward to collaborating towards our shared goal of empowering site success.” For more information about SCRS Global Impact Partners, visit scrsprograms.com. For more information about the Science 37 Metasite, visit www.science37.com. About the Society for Clinical Research Sites The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success. About Science 37Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through our Metasite™ we reach an expanded population beyond the traditional site, delivering on our goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own homes, at their local community provider, or at a traditional site when needed. Our Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.

October 19, 2023 – The Society for Clinical Research Sites (SCRS) is proud to announce Fabian Sandoval, MD, as the recipient of the 2023 Christine K. Pierre Site Impact Award. With more than 25 years of bench-to-bedside research experience, Dr. Sandoval is the President and CEO of Emerson Clinical Research Institute and host of the television show, Tu Salud Tu Familia. The show aims to increase awareness of clinical research in Hispanic communities, reaching more than 2.5 million viewers in the United States, and has won four Emmy Awards as best Health Medical Long Form Content. Dr. Sandoval has also been actively involved with SCRS as a member of its Leadership Council, Global Site Solutions Summit committee, and Diversity Awareness Program for many years. “The namesake of this award, my friend and mentor Christine, left a legacy that encourages and motivates all of us to support one another,” said Dr. Sandoval. “This support is also extended to our patients, and as such, I continue to devote my life and career to the same mission. This recognition is a physical representation of the hard work my team and I do daily to educate and emphasize the importance of diversity in clinical trials.” Allyson Small, SCRS Chief Operating Officer, added, “As a long-standing champion for SCRS, Dr. Fabian Sandoval has served as an influential voice for clinical research sites and underrepresented communities. His commitment to build trust and health equity among diverse populations has fostered a movement of education and advocacy that is nothing short of remarkable. As a true leader and global ambassador for patients and sites, we are honored to recognize Fabian for inspiring a brighter, more equitable future for us all.” The Christine K. Pierre Site Impact Award recognizes an industry leader who has made an extraordinary contribution to furthering the voice of the clinical research site community. Nominations were open to any individuals employed by an SCRS member site. For more information on the Christine K. Pierre Site Impact Award, visit the Global Site Solutions Summit website. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

October 16, 2023 – The Society for Clinical Research Sites (SCRS) has announced that AlzWell and Cedar Health Research are the respective recipients of the 2023 Site Tank Award and Site Patient Recruitment Innovation Achievement Award (SPRIA). Site Tank, sponsored by Pfizer, recognizes a research site that has developed an innovative technology concept designed to enhance, empower and improve clinical research operations. For the Site Tank competition, AlzWell showcased its AI technology that works with Large Language Models (LLMs) to collect patient data and match them with clinical trials. Nicholas Focil, CEO of AlzWell shared, “One of the biggest struggles in the industry is giving patients access to the right clinical trial. New technologies have helped us develop an AI algorithm that empowers and automates the matching process and can determine whether a patient is eligible for any Dementia trial in a matter of seconds. With AlzWell’s mobile application, we hope to empower Alzheimer’s patients directly and revolutionize the clinical trial matching industry.” Sponsored by StudyKIK, SPRIA recognizes a research site that has developed and implemented an innovative patient recruitment program. Cedar Heath Research received the award by highlighting the results of their Aspen Forge platform, which integrated with 500+ physicians and their EMRs for direct access to patient health records. The platform also allowed for better patient connectivity, identification, and recruitment, reducing tedious chart review from 45,000 potential practice patient matches to 1,894 qualified candidates engaged, exceeding sponsor enrollment goals by 150%. “Cedar Health Research was started with the intent to improve patient recruitment in clinical research through community healthcare partnerships. From our inception, we’ve built our organization around innovation to support our recruitment efforts with direct integration of AI/ML patient matching software with EMRs,” says Cedar Health Research CEO, Todd Albin. “Our primary goal is to increase access to clinical trials for both providers and patients alike by reducing barriers of entry through lowering mistrust through deep provider partnerships and patient engagement. With our efforts, we’re seeing accelerated enrollment of diverse populations on our trials and we’re honored to be recognized as the recipient of the 2023 Site Patient Recruitment and Innovation Award.” Jimmy Bechtel, SCRS Vice President of Site Engagement, added, “SCRS congratulates this year’s SPRIA and Site Tank Award winners – AlzWell and Cedar Health Research – for their commitment to advancing clinical research site operations. As the industry strives for enhanced efficiency and engagement with trial participants, these visionary sites have shown us all what is possible when dedication meets innovation. By creating both site and patient-centric solutions, they have transformed patient recruitment initiatives and optimized the performance of their organizations. We were deeply inspired by all the submissions, and eagerly anticipate the positive impact their strategies will have for the future of clinical research.” Three finalists for each award were chosen by an independent selection committee. After finalists presented their initiatives at the Global Site Solutions Summit, winners were chosen by a panel of judges and announced at the SCRS Eagle Award Gala & Awards Dinner in Hollywood, Florida. For more information about the Global Site Solutions Summit and awards, visit sitesolutionssummit.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

October 13, 2023 – The Society for Clinical Research Sites (SCRS) is honored to announce the recipient of the inaugural Global Site Excellence in Diversity Award, Ascension St. John Clinical Research Institute in Tulsa, OK. This prestigious award, sponsored by Syneos Health, recognizes and celebrates the outstanding efforts of clinical research sites worldwide in advancing diversity, equity, and inclusion in clinical trials. In 2019, Ascension St. John’s research department implemented a community outreach plan with the hopes of reshaping not only their department, but their community’s future. By their Bridging Diversity Together (BRIDGE) framework, they focused on not just increasing diversity enrollments, but directly reaching out to the communities they were looking to better serve. The BRIDGE framework shed light on the diverse needs of various demographics within their community, helping Ascension St. John research team cultivate trust and overcome obstacles to trial participation. Stacie Merritt, Director, Ascension St. John Clinical Research Institute, said, “The Ascension St. John clinical research team in Tulsa, Oklahoma is thrilled to receive the inaugural Global Site Excellence in Diversity Award. Our team has worked very hard to make a difference in our community. We are dedicated to placing our patients first and committed to ensuring diversity, equity and inclusion in all of our clinical trials.” Jackie Kent, SCRS Vice President of Diversity & Special Projects, commented, “SCRS received many impressive submissions for the inaugural Global Site Excellence in Diversity Award, which is a testament to sites’ efforts to reshape the future of inclusion and equity for clinical trials. Congratulations to Ascension St. John for earning this prestigious award with their revolutionary BRIDGE framework. By integrating underrepresented community needs synergistically into their mission, they’ve bridged participant knowledge gaps while forging genuine connections within their community. Their strategic commitment to inclusivity and collaboration serves as an inspiration to all.” The award was open to SCRS site members globally and evaluated initiatives such as culturally tailored outreach, community partnerships, educational programs, and recruitment strategies that prioritize diversity and inclusion. The judging panel, consisting of SCRS Diversity Awareness Program committee members, carefully evaluated the submissions and selected the recipient. For more details about the Global Site Excellence in Diversity Award, visit the Global Site Solutions Summit website. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

October 12, 2023 – The Society for Clinical Research Sites (SCRS), the trade organization representing global clinical research sites, is pleased to announce the 2023 recipients of the prestigious SCRS Eagle Award: Merck as the sponsor recipient and Parexel as the CRO recipient. Andy Lee, Senior Vice President and Head, Global Clinical Trial Operations at Merck, shared, “Clinical Research is the foundation for developing new therapies for patients. Without dedicated research sites and staff, we are unable to achieve our societal goals. On behalf of all Sponsors, and particularly Merck, we dedicate this award to all of the patients, sites, staff, IRBs, partners, nurses, CRAs and so many others who work tirelessly to meet our collective goals. We all work together to ensure that ‘No Patient Is Left Behind’ – thank you!” “We are deeply honored to receive this year’s SCRS Eagle Award,” said Teri Karcher, PhD, Executive Vice President, Head of Launch Excellence and Chief Drug Development Officer, Parexel. “Our unwavering commitment to and collaboration with sites is instrumental in our efforts to keep patients at the heart of everything we do. We look forward to our continued work together to improve the clinical research process for the benefit of patients around the world.” Since 2009, the Eagle Award has celebrated outstanding leadership, professionalism, integrity, passion and dedication to advancing clinical research through strong site partnerships. Award selection criteria included willingness to collaborate on protocol design and execution, availability of staff to support sites, responsive communication, and fair contracting, budgeting, and payment schedules. The clinical research site community globally ranked companies they had worked with in the past year that they felt exemplified these characteristics. The sponsor and CRO recipients were selected based on the overall number of votes cast by the global site community. “Consistently listening and working to meet the needs of clinical research sites are truly the core attributes of the SCRS Eagle Award. With nearly 2,500 sites globally participating in the voting process, SCRS is pleased to present this year’s Eagle Award to Merck, as the sponsor recipient and to Parexel as the CRO recipient for 2023,” says Sean Soth, Senior Vice President of Strategy and Partnerships at SCRS. “SCRS and the site community will continue to collaborate with industry on improving the clinical enterprise and appreciate the intentionality the Eagle Award recipients place into site sustainability. Congratulations to Merck and Parexel and to every site working to advance clinical research.” “Facilitating collaboration between sites, CROs, and sponsors to accelerate research is at the core of what we do at Advarra, and we are thrilled to partner with SCRS to present the Eagle Award,” said Elisa Cascade, Chief Product Officer at Advarra. “We know that technology can facilitate stakeholder collaboration in research to improve speed, compliance, and transparency, but the key question is at what cost and level of burden to our sites? Advarra applauds this year’s Eagle Award nominees and winners for their site-centric approach. The industry has made great strides towards simplifying the experience of sites, in parallel to sponsors, CROs, and patients, and we look forward to enabling even greater collaboration in the year ahead.” The awards were presented at the SCRS Global Site Solutions Summit Eagle Award Gala & Awards Dinner, sponsored by Advarra. Learn more about the Global Site Solutions Summit and Eagle Award at sitesolutionssummit.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

October 10, 2023 – Today the Society for Clinical Research Sites (SCRS) is pleased to announce the recipient of the 2023 Excellence in Patient Centricity Award, Velocity Clinical Research. The award, sponsored in 2023 by Sanofi, celebrates a clinical research site that places patient experience at the center of its operations. Velocity Clinical Research demonstrated a strong commitment to patient-centricity and engagement in clinical trials through several innovative initiatives. They established a Patient Advisory Committee (PAC) comprised of diverse clinical trial participants who offer valuable feedback, sharing these insights publicly to improve patient engagement across the industry. Velocity has also prioritized health equity by addressing disparities in clinical research participation by utilizing culturally tailored materials, including resources in Spanish, to ensure inclusivity and accessibility. Velocity also focuses on a diverse workforce to better understand and meet the needs of various communities. Their #VelocityCares program provides employees with cash stipends to donate to charities and engage in spontaneous giving, fostering community support. Nick Spittal, COO of Velocity Clinical Research, commented, “This recognition reaffirms our commitment to putting patients at the heart of everything we do. I’m proud of our entire global team for their embrace of the Velocity core value of ‘care’, working tirelessly to ensure that every participant in a Velocity clinical trial has an exceptional experience. Thank you also to the research volunteers who are essential to the advancement of new therapeutics. We will continue to strive for excellence in delivering innovative and compassionate solutions for the benefit of research participants and their caregivers.” Jimmy Bechtel, SCRS Vice President of Site Engagement, shared, “The Excellence in Patient Centricity award celebrates those who don’t just talk the talk but walk the walk when it comes to patient-centricity. Velocity Clinical Research exemplifies this commitment by consistently putting patients at the heart of their work. SCRS proudly applauds the Velocity team for their industry-leading initiatives that have transformed the patient journey into a seamless experience from start to finish. Their forward-thinking, community-focused programs have set a precedent for the industry, and SCRS is thrilled to recognize and celebrate their unwavering dedication to enhancing the patient experience.” Vicky DiBiaso, Head of Patient Informed Development & Health Value Translation, added, “Sanofi is once again proud to sponsor the annual SCRS Excellence in Patient Centricity Award. We founded this award because we feel a deep appreciation for trial sites, and the pivotal role they play in making clinical research a positive experience, and one that is obtainable to individuals traditionally under-represented. Being able to thank sites going above and beyond is a privilege!” For more information about the Excellence in Patient Centricity Award and the SCRS Global Site Solutions Summit, visit sitesolutionssummit.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

July 31, 2023 — The Society for Clinical Research Sites (SCRS) has announced the launch of its new Global Site Excellence in Diversity Award to recognize and celebrate the exceptional efforts made by clinical research sites in promoting diversity, equity and inclusion within clinical trials. Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization and SCRS Global Impact Partner, is proudly sponsoring the award as part of its commitment to fostering equitable access to clinical trials. The award is open to SCRS site members globally and will evaluate initiatives such as culturally tailored outreach, community partnerships, educational programs, and recruitment strategies that prioritize diversity and inclusion. “At Syneos Health, we are unwavering about our organizational commitment to Diversity By Design™, our integrated approach to improve equitable opportunities across the clinical to commercial continuum through education, awareness, and access,“ said Batisha Anson, Global Head of Patient Diversity & Equity, Syneos Health. “We are proud to partner with SCRS to introduce this novel award that recognizes sites that share both organizations’ dedication to incorporating patient diversity into standard practices to improve scientific knowledge and health equity.” “SCRS is honored to work with Syneos Health to launch this award recognizing the outstanding work of clinical research sites in engaging underrepresented communities,” said Jackie Kent, Vice President of Diversity & Special Projects, SCRS. “By supporting sites that are champions for diverse, equitable and inclusive recruitment, we can collectively address barriers faced by underrepresented populations in clinical research. This award will serve as a testament to sites’ outstanding achievements, enabling solutions for excellence in patient care and diversity initiatives within the healthcare industry. We look forward to seeing the innovative programs developed by sites that are setting an example in this space.” Nominations for the Global Site Excellence in Diversity Award are open from July 31-September 8, 2023. The judging panel, consisting of SCRS Diversity Awareness Program committee members, will evaluate the submissions and select the award recipient. The recipient will be announced at the SCRS Global Site Solutions Summit, which will take place in Hollywood, Florida from October 6-8, 2023. For more information on the Global Site Excellence in Diversity Award, including submission guidelines and eligibility criteria, please visit the Global Site Solutions Summit website. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success. About Syneos HealthSyneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.   We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.  Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.   To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

July 10, 2023 – The Society for Clinical Research Sites (SCRS), a leading global organization dedicated to representing the voice of the clinical research site community, has opened voting for the SCRS Eagle Award. This award recognizes a sponsor and CRO that demonstrates outstanding leadership, professionalism, integrity, operational excellence, and strong site partnerships. Since 2009, the Eagle Award has celebrated the importance of site success within clinical research. Last year, the SCRS Eagle Award recognized Merck and PPD, part of Thermo Fisher Scientific, as the respective sponsor and clinical research organization (CRO) recipient. Selection criteria include site and patient input, communication, payment frequency, fair contract practices, technology approach, diversity and ongoing business partnership. “Sites are resilient resources for both the participants they serve and the study outcomes they drive forward. The Eagle Award honors industry partners who value the balance that sites manage on a daily basis, providing care while managing challenging clinical study operations,” said Sean Soth, SVP of Strategy & Global Business Partnerships, SCRS. “This coveted award foremost recognizes that sites are stakeholders in the clinical research ecosystem and serves as a celebration of the organizations that work to enhance the quality of clinical trials through site collaboration. We encourage all sites to vote with their voice and experience for the organizations that demonstrate great site partnership.” Votes for the SCRS Eagle Award can be submitted online through the SCRS Global Site Solutions Summit website from July 10 through August 26, 2023. Any clinical research site employee will have the opportunity to choose one sponsor and CRO that has exemplified the SCRS Eagle Award attributes within the past 12 months. The recipients of the SCRS Eagle Award will be announced at the SCRS Eagle Award Gala & Awards Dinner, sponsored by Advarra, at the 2023 Global Site Solutions Summit taking place October 6-8, 2023 in Hollywood, Florida. About The Society for Clinical Research Sites (SCRS)Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing more than 10,000 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

June 12, 2023 – The Society for Clinical Research Sites (SCRS) is pleased to announce the addition of Accelerated Enrollment Solutions (AES) as its newest Global Impact Partner. AES is a leading provider of patient recruitment and clinical trial acceleration solutions for the life sciences industry. The SCRS Global Impact Partner program offers industry sponsors, CROs, service providers and site networks an opportunity to align with SCRS’ mission of ensuring site sustainability while contributing to SCRS events, advocacy and educational opportunities for research sites. “On behalf of AES, we are honored to join the Society of Clinical Research Sites Global Impact Partner Program,” said Victor Lopes, M.D., vice president, medical operations. “Our business is committed to actively listening to and supporting the site community. We believe that serving as a Global Impact Partner gives us an excellent opportunity to contribute and enhance the relationships among sites, patients and clinical research organizations.” “SCRS is thrilled to welcome Accelerated Enrollment Solutions as our newest Global Impact Partner,” said Sean Soth, SVP of Global Business Partnerships, SCRS. “Their commitment to patient-centered recruitment and clinical trial acceleration aligns with our mission of advocating for the needs of clinical research sites and improving clinical research for all stakeholders. We look forward to collaborating with the AES team and sharing their expertise on how sites can improve patient recruitment, retention, and engagement in their clinical trials.” For more information about the SCRS Global Impact Partner program, visit scrsprograms.com/global-impact-partnership. About Accelerated Enrollment Solutions (AES) Accelerated Enrollment Solutions (AES), part of the clinical research business of Thermo Fisher Scientific, provides distinctive site solutions and patient enrollment to bring our customers greater certainty in clinical trial conduct. These solutions are available as discrete services or integrated to provide a cohesive and highly differentiated strategy for insourced or outsourced clinical studies, all under results-based commercial terms. We are committed to optimizing each step in the patient journey and delivering best-in-class site performance.  About SCRSFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

May 25, 2023 – The Society for Clinical Research Sites (SCRS) announced today that Takeda has joined the organization as a Global Impact Partner (GIP). The SCRS GIP program provides industry sponsors, CROs, solution providers and sites the opportunity to directly engage with SCRS and its member community. Takeda will provide input on strategic initiatives for the organization and meaningfully contribute to SCRS events, publications and committees. Through this partnership, Takeda will also gain a deeper understanding of the needs of research sites and contribute to the development of forward-thinking solutions in the clinical research marketplace. Marisa Rackley, Takeda Head of CSSE, VP, commented, “As Takeda takes on increased ownership of study execution, it is critical that we build and strengthen relationships with clinical trial sites. We are excited to join SCRS as a Global Impact Partner and look forward to working hand-in-hand with sites to improve clinical trial processes with the aim of delivering medicines to patients faster.” “The Takeda Study Site Engagement team is looking forward to the opportunities to collaborate with our clinical trial sites on their stage. Our hope is that the additional interactions we can achieve via SCRS will increase our understanding of what these sites need to succeed, so as a sponsor we can build lasting, meaningful connections and execute our trials in the most efficient manner,” said Ben Lanning, Takeda’s Head of SSE, Senior Director. “SCRS is pleased to include Takeda as its newest Global Impact Partner,” said Sean Soth, Senior VP of Global Business Partnerships, SCRS. “With a long history of life science development, one of Takeda’s leading values is putting the patient first. This is a value that SCRS member sites recognize, applaud and share each and every day. Our community looks forward to collaborations with the Takeda team.” About Takeda Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com. About SCRSFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

May 10, 2023 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced additions to its Leadership Council after voting by current council members. Established upon the organization’s formation in 2012, the Leadership Council is comprised of site leaders and Global Impact Partners and provides strategic guidance, policy decisions, and oversight for SCRS. These members were chosen based on their involvement with the organization, executive experience in the clinical research industry, and capacity to represent the mission of SCRS. The six new additions to the SCRS Leadership Council include: Diana Foster, PhD, CEO, Total Diversity Clinical Trial Management Rodrigo Garcia, VP, Sites & Patients Center of Excellence, PPD, part of Thermo Fisher Scientific Jane Hiatt, Executive Director, Site Management and Monitoring and ESD, Merck Virginia Nido, Product Development Industry Collaborations, Roche Steve Satek, Chief Commercial Officer, Flourish Research Karri Venn, COO & President, Centricity Research Allyson Small, Chief Operating Officer, SCRS commented, “As a strategic decision-making body, the Leadership Council plays a vital role in shaping the direction of SCRS, and I am confident that the insights and contributions of Diana, Rodrigo, Jane, Virginia, Steve and Karri will have a positive impact on the organization’s continued growth and success. Their experience and expertise in advocating for the needs of clinical research sites will guide SCRS forward in many positive ways.” To see a list of current Leadership Council members, visit myscrs-new.local/about/leadership-council. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

April 17, 2023– The Society for Clinical Research Sites (SCRS) today announced a Global Impact Partnership with DM Clinical Research, a growing and diverse site network with 13 dedicated research centers nationally. DM Clinical Research was the first official site network to join the SCRS Global Impact Partner (GIP) program. As a GIP, DM Clinical Research will expand its working relationship with SCRS to further amplify the site voice within the clinical research community. DM Clinical Research CEO and Founder Mohammad Millwala is an active member of the SCRS Leadership Council and co-chair of the Diversity Awareness Program. “The industry leadership opportunities provided through SCRS are quite valuable,” said Millwala. “DM Clinical Research is excited to be the first site network to join the Global Impact Partner Program. We look forward to bringing our perspective and experiences to this important initiative and encourage our industry colleagues to similarly partner with SCRS.” “The DM Clinical Research team has been a leader for clinical research sites around the globe, excelling in innovative patient-centric practices and ensuring diverse representation throughout their organization and the communities they serve,” said Sean Soth, SCRS Vice President of Global Business Partnerships. “SCRS applauds DM Clinical Research for taking important steps to ensure site voices are heard and collaborate with industry partners dedicated to developing site-focused programs and resources.” About DM Clinical Research DM Clinical Research is an integrated national network of clinical trial sites headquartered in Houston, Texas. Founded in 2006, the company includes 13 dedicated research centers and a network of affiliate sites, servicing a range of therapeutic areas, including vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, women’s health, and more. DM Clinical Research received the 2023 Best Clinical Trial Network Vaccine Industry Excellence Award and the Society for Clinical Research Sites 2022 Excellence in Patient Centricity Award. Through its partnerships with prominent global pharmaceutical sponsors, DM Clinical Research brings opportunities to the community to participate in cutting-edge research, under the careful medical supervision of qualified physicians and professionals. For more information, please visit DMClinical.com or call (281) 517-0550. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

April 10, 2023 – Today the Society for Clinical Research Sites (SCRS) announced that Flourish Research has joined the organization as a Global Impact Partner (GIP). Flourish is known as one of the industry’s most progressive and diversified clinical trial companies with robust capabilities in the therapeutic areas of cardiology, metabolic disorders, CNS, and vaccines. As part of this partnership, Flourish Research will align with more than 50 other Global Impact Partners comprised of site networks, sponsors, CROs, and solution providers dedicated to establishing collaborative solutions that improve clinical research processes and ensure site sustainability. Steve Satek, Chief Commercial Officer of Flourish Research said, “We’re honored to become a Global Impact Partner because SCRS has had such an enormous impact on Flourish Research sites. A number of the original founders of Flourish Research have been active leaders within SCRS over the years, from Chairing the Global Site Solutions Summit, to participating in Site Advocacy Groups, to speaking engagements on behalf of SCRS. We value the collective depth of knowledge, sharing, community, and education that this partnership brings.” “The Flourish Research team has been a valuable contributor to SCRS for years,” commented Sean Soth, SCRS Vice President of Global Business Partnerships. “We are thrilled to expand our partnership further and welcome them to our evolving Global Impact Partner program. GIPs are eager to hear from sites, and Flourish will help further bridge the gap between industry partners and site networks to create forward-thinking programs and technology that benefit sites, patients, and the industry as a whole.” About Flourish Research Flourish Research is a leading clinical trial site network that was founded to address the highly fragmented clinical trial site market. Flourish provides sponsors and CROs with increased speed and efficiency across a variety of therapeutic areas and indications, while offering a single point of entry to multiple sites. Flourish currently has locations in Florida, Illinois, Pennsylvania, and Texas. For additional information on Flourish, visit https://flourishresearch.com/ About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

March 28, 2023 – The Society for Clinical Research Sites (SCRS) announced today that IMA Clinical Research has become a Global Impact Partner (GIP). IMA Clinical Research is a clinical trial site network providing extensive, nationwide patient access across multiple therapeutic areas. As a GIP, IMA has the opportunity to work with the SCRS Leadership Council and various committees to identify and pursue strategic initiatives for SCRS and its global community of clinical research sites. “We are thrilled to join SCRS’ Global Impact Partnership,” said Dana Poff, Executive Vice President at IMA Clinical Research. “We believe this alliance will provide a unique opportunity for us to engage with SCRS and its members. We’re excited to be a part of various initiatives with SCRS, like the Diversity Awareness Program and Digital Innovation Initiative to support the continued advancement of providing patients greater access to clinical trials. We’re also looking forward to working alongside other sponsors, CROs, and professional providers to make a meaningful impact on clinical research.” Sean Soth, SCRS VP of Global Business Partnerships, added, “As an accomplished site network, IMA has been an ongoing voice through membership and Site Solutions Summit participation for many years. SCRS is pleased to welcome the IMA team into the Global Impact Partner Program, as they lend their patient, care, and centralized experience to multiple SCRS initiatives and work throughout the year.” About IMA Clinical Research IMA Clinical Research, a division of The IMA Group, is a physician-founded network of comprehensive clinical research sites specializing in Phase II-IV clinical trials in multi-therapeutic areas. IMA Clinical Research conducts site-based, hybrid and fully decentralized clinical trials that support the development of safe and effective new treatments. For more information, visit www.imaresearch.com About SCRS Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.  [EH1]This is mentioned in the first paragraph, might be repetitive writing if we include it here too its fine with one edit, change multiple to multi in both.  [DN2]  actually just in the bottom  [DN3]